VRAX

Virax Biolabs (VRAX)

Virax Biolabs Group Ltd

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VRAX

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/04/25	21:00	PR Newswire (US)	Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/04/16	20:30	PR Newswire (US)	Virax Biolabs to Participate at ESCMID Global 2024	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/03/16	05:30	PR Newswire (US)	Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/01/23	07:28	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/01/23	07:27	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2024/01/12	21:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	21:34	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	21:30	PR Newswire (US)	Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:06	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/21	06:03	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/18	21:37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/18	21:30	PR Newswire (US)	Virax Biolabs' CEO James Foster Issues Letter to Shareholders	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/18	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/14	21:43	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/14	21:30	PR Newswire (US)	Virax Biolabs Group Limited Announces 1-for-10 Share Consolidation	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/08	20:03	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/12/06	06:06	Edgar (US Regulatory)	Form F-3 - Registration statement by foreign private issuers	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/11/09	06:11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/11/01	05:38	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/10/18	05:05	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/10/12	21:00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/10/04	20:24	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/09/12	20:49	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/09/12	20:30	PR Newswire (US)	Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/09/01	20:37	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/09/01	20:30	PR Newswire (US)	Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/08/03	21:39	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:VRAX	Virax Biolabs Group Ltd
2023/08/03	20:30	PR Newswire (US)	Nasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 Bid	NASDAQ:VRAX	Virax Biolabs Group Ltd